Results 141 to 150 of about 48,143 (212)

Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19). [PDF]

Cureus, 2020
Solaimanzadeh I.
europepmc   +1 more source

A developmentally regulated and cAMP-repressible gene of Dictyostelium discoideum: cloning and expression of the gene encoding cyclic nucleotide phosphodiesterase inhibitor

, 1990
Lin Wu, Jakob Franke
openalex   +1 more source

Substituted 1,8-Naphthyridin-2(1H)-ones as Selective Phosphodiesterase IV Inhibitors.

, 1994
Akihiro Matsuura, Naoki Ashizawa, Reiji Asakura, T Kumonaka, T Aotsuka, Tadashi Hase, Chikako Shimizu, T. KURIHARA, F. Kobayashi   +8 more
openalex   +2 more sources

The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide [PDF]

, 1996
Saleh Al‐Alaiyan, Abbas Al-Omran, David Dyer   +2 more
openalex   +1 more source

Rolipram, a Selective Inhibitor of Phosphodiesterase Type 4, Pronouncedly Enhanced the Forskolin-Induced Promotion of Dopamine Biosynthesis in Primary Cultured Rat Mesencephalic Neurons.

, 1997
Nobuyuki Yamashita, Mio Miyashiro, Jun Baba, Aiko Sawa   +3 more
openalex   +2 more sources

Inhibitory effect of a novel selective and potent phosphodiesterase type V inhibitor, E4021, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.

, 1994
Kohtarou Kodama, Hideyuki Adachi, Nobuyuki Mori   +2 more
openalex   +1 more source

Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer [PDF]

, 1996
John E. Souness, Miriam Griffin, Christopher Maslen, Karen Ebsworth, Lisa C. Scott, Kenneth H. Pollock, Malcolm N. Palfreyman, Jan‐Anders Karlsson   +7 more
openalex   +1 more source

Metabolic products of microorganisms. 268. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. II. Minor components belonging to the obscurolide B to D series.

, 1993
M. RITZAU, SIEGRID PHILIPPS, Axel Zeeck, HUBERT HOFF, Hans Zähner   +4 more
openalex   +2 more sources

Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer [PDF]

, 1997
John E. Souness, Clare Houghton, Nughat Sardar, Michael T. Withnall   +3 more
openalex   +1 more source

Effect of E1020(Phosphodiesterase inhibitor III) on hemodynamics and its blood concentration in acute congestive cardiac insuffciency.

, 1991
RINJI MURAKAMI
openalex   +2 more sources